Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial

Mov Disord. 2011 Feb 1;26(2):358-9. doi: 10.1002/mds.23423. Epub 2010 Oct 19.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Humans
  • Injections, Subcutaneous
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / therapeutic use*
  • Prospective Studies
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use*
  • Spinocerebellar Ataxias / drug therapy*
  • Treatment Outcome

Substances

  • Recombinant Proteins
  • Insulin-Like Growth Factor I